Last $4.40 USD
Change Today -0.07 / -1.57%
Volume 1.9M
NVAX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Russell P. Wilson J.D.

Former Senior Vice President of Business Development, Novavax, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

54$592,852
As of Fiscal Year 2013

Background*

Mr. Russell P. Wilson, also known as Rip, had been a Senior Vice President of Business Development at Novavax, Inc. since November 7, 2011. Mr. Wilson had been responsible for developing business alliances, license arrangements, and partnering opportunities with pharmaceutical companies and government agencies. He served as the Chief Financial Officer, Principal Accounting Officer and Vice President at Supernus Pharmaceuticals, Inc. since 2009 until October 2011. Mr. ...

Read Full Background

Corporate Headquarters*

20 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-268-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Princeton University
JD
University of Virginia
MBA
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$317,316
Total Annual Compensation$317,316

Stock Options*

All Other Compensation$8,540
Exercisable Options131,250
Exercisable Options Value$490,250
Unexercisable Options293,750
Unexercisable Options Value$1,031,750
Total Value of Options$1,522,000
Total Number of Options425,000

Total Compensation*

Total Annual Cash Compensation$442,852
Total Short Term Compensation$317,316
Other Long Term Compensation$8,540
Total Calculated Compensation$592,852
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVAX:US $4.40 USD -0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVAVAX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.